We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

U.S. to cut automotive tariffs as Japan enters TPP talks

  • Foley & Lardner LLP
  • -
  • Japan, USA
  • -
  • May 6 2013

On April 24, 2013, Acting U.S. Trade Representative ("USTR") Demetrios Marantis formally notified Congress that the United States plans to include

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Japan’s entry into free trade talks presents challenges for the automotive sector

  • Foley & Lardner LLP
  • -
  • Japan, USA
  • -
  • March 28 2013

Japanese Prime Minister Shinzo Abe's announcement that Japan will join talks on the Trans-Pacific Pacific Partnership ("TPP") presents potential

Japan, S. Korea, and Germany lead in nanotech patenting for non-USA countries

  • Foley & Lardner LLP
  • -
  • Germany, Japan, South Korea, USA
  • -
  • May 4 2011

From the beginnings of the NNI, the "race" between the industrialized countries to develop nanotechnology was a focus point

USPTO offers relief for patentees and applicants in Japan

  • Foley & Lardner LLP
  • -
  • Japan, USA
  • -
  • March 18 2011

In a Notice published March 17, 2011, the USPTO indicated that it is offering relief to patentees and applicants in Japan

Public company disclosures after the natural disasters in Japan

  • Foley & Lardner LLP
  • -
  • Japan, USA
  • -
  • March 16 2011

While Japan and the world are still trying to assess the impact of the catastrophic earthquake and tsunami that struck parts of Japan last week, including the terrible human and economic toll that is still unfolding, a U.S. public company should consider whether it should publicly disclose the effects or potential effects on it